Literature DB >> 27707940

Chlorhexidine versus Tincture of Iodine for Reduction of Blood Culture Contamination Rates: a Prospective Randomized Crossover Study.

Elizabeth Story-Roller1, Melvin P Weinstein2,3.   

Abstract

Blood cultures (BCs) are the standard method for diagnosis of bloodstream infections (BSIs). However, the average BC contamination rate (CR) in U.S. hospitals is 2.9%, potentially resulting in unnecessary antibiotic use and excessive therapy costs. Several studies have compared various skin antisepsis agents without a clear consensus as to which agent is most effective in reducing contamination. A prospective, randomized crossover study directly comparing blood culture contamination rates using chlorhexidine versus iodine tincture for skin antisepsis was performed at Robert Wood Johnson University Hospital (RWJUH). Eight nursing units at RWJUH were provided with blood culture kits containing either chlorhexidine (CH) or iodine tincture (IT) for skin antisepsis prior to all blood culture venipunctures, which were obtained by nurses or clinical care technicians. At quarterly intervals, the antiseptic agent used on each nursing unit was switched. Analyses of positive BCs were performed to distinguish true BSIs from contaminants. Of the 6,095 total BC sets obtained from the participating nursing units, 667 (10.94%) were positive and 238 (3.90%) were judged by the investigators to be contaminated. Of the 3,130 BCs obtained using IT, 340 (10.86%) were positive and 123 (3.93%) were contaminated. Of 2,965 BCs obtained using CH, 327 (11.03%) were positive and 115 (3.88%) were contaminated. The rates of contaminated BCs were not statistically significant between the two antiseptic agents (P = 1.0). We conclude that CH and IT are equivalent agents for blood culture skin antisepsis.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27707940      PMCID: PMC5121392          DOI: 10.1128/JCM.01457-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Contaminant blood cultures and resource utilization. The true consequences of false-positive results.

Authors:  D W Bates; L Goldman; T H Lee
Journal:  JAMA       Date:  1991-01-16       Impact factor: 56.272

2.  Doing it right the first time: quality improvement and the contaminant blood culture.

Authors:  F I Weinbaum; S Lavie; M Danek; D Sixsmith; G F Heinrich; S S Mills
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Chlorhexidine compared with povidone-iodine as skin preparation before blood culture. A randomized, controlled trial.

Authors:  O Mimoz; A Karim; A Mercat; M Cosseron; B Falissard; F Parker; C Richard; K Samii; P Nordmann
Journal:  Ann Intern Med       Date:  1999-12-07       Impact factor: 25.391

4.  A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: effects on rates of blood culture contamination.

Authors:  J R Little; P R Murray; P S Traynor; E Spitznagel
Journal:  Am J Med       Date:  1999-08       Impact factor: 4.965

5.  Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department.

Authors:  Rita M Gander; Linda Byrd; Michael DeCrescenzo; Shaina Hirany; Michelle Bowen; Judy Baughman
Journal:  J Clin Microbiol       Date:  2009-01-26       Impact factor: 5.948

6.  Blood culture contamination: a randomized trial evaluating the comparative effectiveness of 3 skin antiseptic interventions.

Authors:  Laraine L Washer; Carol Chenoweth; Hae-Won Kim; Mary A M Rogers; Anurag N Malani; James Riddell; Latoya Kuhn; Bernard Noeyack; Harry Neusius; Duane W Newton; Sanjay Saint; Scott A Flanders
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-26       Impact factor: 3.254

7.  Comparison of chlorhexidine and tincture of iodine for skin antisepsis in preparation for blood sample collection.

Authors:  Joan Barenfanger; Cheryl Drake; Jerry Lawhorn; Steven J Verhulst
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

  7 in total
  4 in total

1.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

Review 2.  Practical Guidance for Clinical Microbiology Laboratories: A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem

Authors:  Gary V Doern; Karen C Carroll; Daniel J Diekema; Kevin W Garey; Mark E Rupp; Melvin P Weinstein; Daniel J Sexton
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

3.  Initial Specimen Diversion Device Utilization Mitigates Blood Culture Contamination Across Regional Community Hospital and Acute Care Facility.

Authors:  Mark D Povroznik
Journal:  Am J Med Qual       Date:  2022-03-30       Impact factor: 1.200

4.  Blood Culture Contamination: A Single General Hospital Experience of 2-Year Retrospective Study.

Authors:  Anna Tenderenda; Monika Łysakowska; Robert Dargiewicz; Anna Gawron-Skarbek
Journal:  Int J Environ Res Public Health       Date:  2022-03-04       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.